JPRN-jRCT1061230097
Recruiting
未知
A study to verify the acute therapeutic effect of mepolizumab for eosinophilicpolyangiitis granulomatosis (EGPA) neuropathy(A Prospective Observational Study)
Takeshita Yukio0 sites20 target enrollmentFebruary 1, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Takeshita Yukio
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Patients \=\<30 day after onset of EGPA neuropathy.
- •2\) Patients who treated with steroid\-pulse therapy (3 days) during the acute phase of EGPA neuropathy and shown no complete remission in EGPA neuropathy.
- •3\) Patients who meet the American Society of Rheumatology EGPA classification criteria or American College of Rheumatology/European League Against Rheumatism EGPA classification criteria.
- •4\) Patients aged 20 years or older at the time of onset of EGPA neuropathy.
- •5\) Regardless of gender.
- •6\) Patients who gave informed consent to participate in the study by the patient or the legally acceptable
- •representative after receiving adequate explanation for their participation in the study.
Exclusion Criteria
- •1\) Patients being treated with mepolizumab
- •2\) Patients who received steroid\-pulse therapy (3 days) in the acute phase of EGPA neuropathy and had complete EGPA neuropaty resolution.
- •3\) Life\-threatening patients
- •4\) Patients who were judged inappropriate by principal investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Therapeutic effect of autologous adipose tissue derived stromal vascular fraction to neuropathic pain syndrome; Preliminary reportSymptoms, signs and abnormal clinical and laboratory findings, NECKCT0006517Hanyang University10
Recruiting
Not Applicable
Verification of the therapeutic effect given to a child with a mental problem by horse-mediated activityAutism, ADHD, Neurosis, etcJPRN-UMIN000033358agoya Ishida Gakuen, Seijoh University34
Not yet recruiting
Phase 2
sefulness of Homoeopathic Medicine in the management of Lichen PlanusHealth Condition 1: L43- Lichen planusCTRI/2024/01/061087Dr.Anjumol K K
Completed
Phase 1
177Lu-FAPI in cancer therapyIRCT20211206053304N1Iran University of Medical Sciences10
Not yet recruiting
Not Applicable
Ayurvedic Management in UrticariaHealth Condition 1: L502- Urticaria due to cold and heatCTRI/2020/08/027062Parul Institute of Ayurveda Vodadara Gujarat